Comparison of Amikacin Lung Delivery With Two Nebulizers
NCT02538588 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2015-09-02
Summary
Comparison between two modalities of nebulization.
Conditions
- Healthy
- Cystic Fibrosis
Interventions
- DEVICE
-
Nebulizer 1
- DEVICE
-
Nebulizer 2
Sponsors & Collaborators
-
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 16 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2015-09-30
- Completion
- 2015-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Implementation of a Non-invasive Version of the Imaging β-adrenergic-dependent Sweat Secretion Test
NCT03584841 ·Status: UNKNOWN ·Phase: NA
-
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
NCT06188988 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of New Device for Beta-adrenergic Sweat Test in the Context of Stratification of Patient With Cystic Fibrosis
NCT06836453 ·Status: RECRUITING ·Phase: NA
-
Effects of SIMEOX on Airway Clearance in Cystic Fibrosis
NCT04187924 ·Status: COMPLETED ·Phase: NA
-
The Challenge of Obtaining Qualitative Bacterial Cultures in Non-expectorating Cystic Fibrosis Patients
NCT02363764 ·Status: COMPLETED
-
Breath Condensate Study in Patients With Cystic Fibrosis.
NCT02056132 ·Status: COMPLETED
-
Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis
NCT01799642 ·Status: COMPLETED
-
Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease
NCT00934362 ·Status: COMPLETED ·Phase: PHASE2
-
Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.
NCT02309229 ·Status: COMPLETED
-
Cough-Generated Aerosols of NTM in Cystic Fibrosis
NCT01815866 ·Status: COMPLETED
-
Functional Respiratory Imaging and Orkambi in CF
NCT03956589 ·Status: TERMINATED ·Phase: PHASE4
-
Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function
NCT01685801 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects
NCT01768663 ·Status: COMPLETED ·Phase: PHASE1
-
Mucin in Sputum of CF During Pulmonary Exacerbation
NCT00202072 ·Status: UNKNOWN
-
Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis
NCT02308267 ·Status: UNKNOWN
-
Impact of Immunonutrition on the Patients With Cystic Fibrosis
NCT02048592 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Peripherally Inserted Venous Catheters in Cystic Fibrosis Patients
NCT03674216 ·Status: COMPLETED
-
Orkambi Exercise Study
NCT02821130 ·Status: COMPLETED
-
Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis
NCT01537614 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
NCT03000348 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of Breath Volatile Organic Compounds in Early Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis
NCT05944367 ·Status: COMPLETED
-
Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis
NCT00721071 ·Status: COMPLETED ·Phase: PHASE2
-
Miglustat in Cystic Fibrosis
NCT00742092 ·Status: COMPLETED ·Phase: PHASE2
-
Near Patient Microbial Testing in Cystic Fibrosis
NCT01877707 ·Status: COMPLETED ·Phase: NA
-
Taste Receptors Regulation in CF Patients
NCT04058340 ·Status: UNKNOWN ·Phase: NA